Novel kirkovirus linked to equine colitis cases in early study: full analysis

A new study suggests a novel kirkovirus may be associated with equine gastrointestinal disease, adding a possible viral lead to one of equine medicine’s more frustrating diagnostic gaps. In the paper, published November 18, 2025, in Equine Veterinary Journal, North Carolina State University researchers and collaborators reported that the virus was found more often in horses with colitis than in horses with colic or clinically normal controls. (news.ncsu.edu)

That matters because equine colitis is clinically serious and often fast-moving, yet the cause remains unidentified in a large share of cases. Reviews of equine enterocolitis note that even with modern diagnostics, roughly half of cases remain undifferentiated. Known infectious causes include Salmonella spp., Clostridioides difficile, Clostridium perfringens, Neorickettsia risticii, and equine coronavirus, but those pathogens don’t explain every outbreak or every sporadic case. (mdpi.com)

In the new study, investigators first performed next-generation sequencing on 13 pooled fecal samples from horses with enterocolitis, with five horses per pool. They identified a full genome for a novel kirkovirus in 5 of the 13 pools. They then designed qPCR assays and tested 218 fecal samples collected between 2020 and 2025, divided into colitis, colic, and clinically normal groups. The virus was detected in 24% of the colitis group, versus 5.4% of the colic group and 6.7% of clinically normal horses. Most kirkovirus-positive horses in the colitis group were tied to two farm-wide gastrointestinal disease outbreaks, and 25% of positive cases also had small colon impactions. The authors also noted an apparent seasonal pattern, with cases presenting in autumn, winter, and spring. (news.ncsu.edu)

The work builds on earlier virome research in horses. A 2015 Journal of General Virology paper had already described a kirkovirus-like genome in the liver and spleen of a horse with fatal idiopathic hepatopathy, but that report did not establish a gastrointestinal association. The new study is the first to connect a novel equine kirkovirus with enterocolitis cases and to suggest it may be relevant in outbreak investigations. (pubmed.ncbi.nlm.nih.gov)

NC State framed the findings as an early but potentially important clue. In the university’s release, first author Lilly Haywood noted that horses are especially vulnerable to the downstream effects of colitis because inflammation in the large intestine can quickly lead to dehydration and, in severe cases, sepsis. Corresponding author Breanna Sheahan said the team began looking for an additional viral cause because in more than 50% of cases the cause of colitis still can’t be identified. She also emphasized that identifying a pathogen is the first step toward future therapeutics, while cautioning that the current work does not prove the virus caused illness. (news.ncsu.edu)

Why it matters: For veterinary professionals, the study is less about an immediate practice change than about sharpening clinical suspicion in unresolved cases. A virus detected in about one-quarter of colitis samples, but in only a small minority of control samples, is enough to justify follow-up work on diagnostics, tissue tropism, transmission, and case definition. It may be particularly relevant when clinicians are facing clustered cases on a farm or an unusual overlap between colitis and small colon impaction. At the same time, the study’s limitations are important: it was retrospective, relied on fecal detection, and the authors were unable to definitively demonstrate infection in equine gastrointestinal tissues. That means veterinarians should view kirkovirus today as a plausible marker or contributor, not a confirmed cause. (news.ncsu.edu)

The broader industry implication is diagnostic. If future studies confirm pathogenicity, equine diagnostic labs could eventually add kirkovirus testing to workups for acute enterocolitis or outbreak investigations. But before that happens, the field will need replication in other populations, prospective sampling, and clearer evidence that the virus is doing more than traveling through feces. Researchers will also need to sort out whether kirkovirus is a primary pathogen, an opportunist, or a bystander associated with other disruptions in the gut. (news.ncsu.edu)

What to watch: Watch for tissue-based studies, prospective outbreak investigations, and any movement by academic or commercial labs toward research-use PCR assays, which would signal that the finding is starting to translate from discovery science into clinical diagnostics. (news.ncsu.edu)